comparemela.com

Latest Breaking News On - அமரின் நிறுவனம் - Page 3 : comparemela.com

CinCor Pharma Announces Appointments of Three Experienced

CinCor Pharma Announces Appointments of Three Experienced
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Amarin Corp (AMRN) Highlights Multiple Scientific Findings for VASCEPA and Its Unique Active Ingredient at ACC

Amarin Corp (AMRN) Highlights Multiple Scientific Findings for VASCEPA and Its Unique Active Ingredient at ACC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology s 70th Annual Scientific Session

Share: Post hoc analyses by estimated on-treatment serum EPA levels in the VASCEPA group suggest potentially reduced incidence of new heart failure and new heart failure requiring hospitalization with higher achieved serum EPA levels Amarin to Webcast Discussion of Data Presented at ACC.21 Monday, May 17, 2021 at 4:30 p.m., Eastern Time DUBLIN, Ireland and BRIDGEWATER, N.J., May 15, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of REDUCE-IT ® HEART FAILURE (HF) at ACC.21, the American College of Cardiology s 70th Annual Scientific Session, being held virtually from May 15 – 17, 2021. These new analyses supported by Amarin were presented on behalf of all authors by Deepak L. Bhatt, M.D., M.P.H., Brigham and Women s Hospital, Harvard Medical School, Boston, MA.

10 Biggest Price Target Changes For Wednesday

Amarin (AMRN) Q1 2021 Earnings Call Transcript

Amarin (AMRN) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Amarin (NASDAQ: AMRN) Welcome to Amarin Corporation s conference call to discuss its first-quarter 2021 financial results and operational updates. This conference call is being recorded today, April 29, 2021. I would like to turn the conference call over to Alina Doubrovna, associate manager of investor relations at Amarin. Alina Doubrovna Associate Manager of Investor Relations Thank you, operator, and thank you to everyone for joining our first-quarter 2021 results. Before we begin, let me turn to our forward-looking statements. Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act. Examples of such statements include, but are not limited to: our current expectations regarding our com

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.